MANNELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.302
EU - Europa 7.893
AS - Asia 1.663
AF - Africa 47
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 22.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.261
RU - Federazione Russa 2.560
PL - Polonia 1.615
IE - Irlanda 862
SE - Svezia 843
IT - Italia 754
SG - Singapore 537
HK - Hong Kong 386
UA - Ucraina 379
CN - Cina 310
DE - Germania 305
FI - Finlandia 213
IN - India 175
GB - Regno Unito 139
JO - Giordania 104
CH - Svizzera 87
VN - Vietnam 70
FR - Francia 49
CA - Canada 41
KR - Corea 39
TR - Turchia 36
CI - Costa d'Avorio 32
BE - Belgio 31
ES - Italia 18
NL - Olanda 12
AT - Austria 11
SC - Seychelles 10
NZ - Nuova Zelanda 6
BG - Bulgaria 5
CZ - Repubblica Ceca 4
AU - Australia 3
EU - Europa 3
JP - Giappone 3
MU - Mauritius 3
GR - Grecia 2
BR - Brasile 1
BY - Bielorussia 1
CM - Camerun 1
GE - Georgia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 22.918
Salva come PNG Salva come JPEG
Città #
Fairfield 1.963
Santa Clara 1.631
Warsaw 1.610
Woodbridge 936
Ashburn 895
Chandler 865
Dublin 861
Seattle 787
Cambridge 781
Houston 689
Jacksonville 637
Wilmington 623
Singapore 440
Ann Arbor 362
Princeton 260
Lawrence 253
Altamura 230
Hong Kong 189
Boardman 157
Boston 151
Mumbai 141
Florence 135
Beijing 123
Medford 121
Moscow 103
San Diego 99
Buffalo 90
Bern 84
Shanghai 73
West Jordan 62
Dong Ket 59
Milan 46
New York 46
Norwalk 41
Seoul 38
Falls Church 36
Abidjan 32
Izmir 32
Brussels 30
Kent 30
Hillsboro 29
Los Angeles 29
Toronto 28
Voghera 22
Yubileyny 22
Andover 21
Bologna 18
Prato 18
Pune 18
Barcelona 16
Bremen 15
Helsinki 15
Phoenix 14
Zola Predosa 14
Frankfurt Am Main 11
Vienna 11
Auburn Hills 10
Redwood City 10
Munich 9
Redmond 9
London 8
Old Bridge 8
Guangzhou 7
Ottawa 7
Saint Petersburg 7
Düsseldorf 6
Laurel 6
Nanjing 6
Philadelphia 6
Rome 6
Verona 6
Chennai 5
Dearborn 5
Paris 5
Pisa 5
Rui'an 5
Sofia 5
Wuhan 5
Auckland 4
Chiswick 4
Lappeenranta 4
Salerno 4
Trieste 4
Venice 4
Borgo San Giacomo 3
Brooklyn 3
Cedar Knolls 3
Detroit 3
Grosseto 3
Kilburn 3
Leawood 3
Naaldwijk 3
Padova 3
Pittsburgh 3
San Mateo 3
Shenzhen 3
Xi'an 3
Ariano nel Polesine 2
Biloxi 2
Brno 2
Totale 16.257
Salva come PNG Salva come JPEG
Nome #
(0) Save to: more options SPECT semiquantitative analysis of adrenocortical. I-131-6 beta-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma 465
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 271
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 261
Incidental and metastatic adrenal masses 254
Metformin as a new anti-cancer drug in adrenocortical carcinoma 246
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. 235
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 233
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 228
Feasibility and safety of minimal-incision thyroidectomy for Graves' disease: A prospective, single-center study 227
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 227
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 226
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 171
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 170
A case of malignant insulinoma responsive to somatostatin analogs treatment 168
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 163
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 145
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 144
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model 144
Rare diseases in clinical endocrinology: a taxonomic classification system. 142
Analysis of circulating microRNAs in adrenocortical tumors. 140
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? 136
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 132
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 131
Il dosaggio delle metanefrine nella diagnosi del feocromocitoma: vantaggi clinici e problematiche di laboratorio 129
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 129
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 129
Effects of thyroid replacement therapy on catecholamine plasma levels. 127
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 126
A case of hyponatremia caused by central hypocortisolism 126
Localization of endothelin-converting enzyme-1 in human kidney 125
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 125
Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy 124
A unique neuroendocrine cell model derived from the human foetal neural crest. 124
Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules 124
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. 123
Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. 122
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 122
A further case of giant intrasellar carotid aneurysm mimicking a pituitary adenoma: the relevance of a multivariate approach in differential diagnosis. 122
Genetic screening for pheochromocytoma: should SDHC gene analysis be included? 120
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. 120
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. 120
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 119
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 119
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 119
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer 119
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. 119
Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas. 119
Presence and distribution of endothelin-1 gene expression in human kidney. 118
A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. 118
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 118
Adrenal medulla secretion in Cushing's syndrome. 116
The Y606C RET mutation causes a receptor gain of function. 115
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 114
Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. 113
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 113
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 111
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 111
Pheochromocytoma in Italy: a multicentric retrospective study. 110
Biochemistry, genetics and therapy of malignant pheochromocytomas. 109
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 109
Integrated genomic characterization of adrenocortical carcinoma. 109
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series. 109
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 108
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 108
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 108
Caratterizzazione genomica del carcinoma surrenalico 108
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency. 108
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 107
Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. 107
Ipertensione ed esercizio fisico 107
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. 107
Multi-step approach in a complex case of Cushing's syndrome and medullary thyroid carcinoma. 106
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 106
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 106
Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or non-functional paragangliomas. 106
Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture 106
[Diagnostic problems in pheochromocytoma] 105
Hyponatremia and pituitary adenoma: think twice about the etiopathogenesis. 104
The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells 104
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 104
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 104
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 103
False serum calcitonin high levels using a non-competitive two-site IRMA. 102
Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHx Gene Mutation 101
Adjuvant mitotane treatment for adrenocortical carcinoma 101
Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia. 101
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 101
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 100
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma 100
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma 98
Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. 98
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 98
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. 97
Pheochromocytoma: a permanent challenge for the clinical Endocrinologist. 96
An analogue of met-enkephalin attenuates the pituitary-adrenal response to ovine corticotrophin releasing factor. 96
Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension. 96
Naloxone administration releases catecholamines. 95
Does endogenous dopamine modulate human sympathetic activity through DA2 receptors? 95
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 95
Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. 94
Totale 13.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.164 0 0 0 0 456 561 478 557 453 248 340 71
2020/20212.682 188 185 250 234 115 366 87 272 230 353 154 248
2021/20221.583 49 134 119 69 72 94 54 120 95 93 256 428
2022/20233.936 418 695 179 279 319 721 498 184 380 29 121 113
2023/20241.384 67 156 253 79 98 166 35 241 27 122 92 48
2024/20255.509 345 1.045 598 1.483 2.038 0 0 0 0 0 0 0
Totale 23.139